secwatch.observer — SEC 8-K summary
======================================

Issuer:     Calidi Biotherapeutics, Inc. (CLDI)
CIK:        0001855485
Form:       8-K
Filed at:   2024-10-24T23:59:59+00:00
Accession:  0001493152-24-042406
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Calidi Biotherapeutics raises $2M in registered direct offering and private placement of warrants
--------------------------------------------------------------------------------

- Sold 2,050,000 shares at $1.00 per share in a registered direct offering.
- Concurrent private placement: Series E and F warrants to purchase up to 2,050,000 shares each at $1.13, exercisable after 6 months.
- Gross proceeds ~$2 million; net proceeds for working capital and clinical trials.
- Placement agent Ladenburg Thalmann receives 8% cash fee and warrants for 102,500 shares at $1.25.
- Lock-up agreements: Company 30 days, directors/officers 90 days from closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855485/000149315224042406/0001493152-24-042406-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855485/000149315224042406/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-042406

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer